Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
05 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250505730127/en/Tempus-Announces-Notetaker-its-AI-Powered-Clinical-Assistant-for-Psychiatry
01 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250501599569/en/Tempus-TIME-Network-Expands-Support-of-Phase-I-Clinical-Trials-To-Accelerate-Activation-and-Enrollment
29 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250429855224/en/Tempus-Publishes-Study-Validating-the-Benefits-of-xF-its-Comprehensive-Liquid-Biopsy-Assay-for-Therapy-Selection
28 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250428612362/en/Tempus-Introduces-Loop-an-AI-Powered-Target-Discovery-and-Validation-Platform
25 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250425840107/en/Tempus-Announces-18-Abstracts-Accepted-for-Presentation-at-the-American-Association-for-Cancer-Research-Annual-Meeting-2025
23 Apr 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/tempus-ai-line-200m-astrazeneca-pathos-deal-develop-cancer-model
ABOUT THIS PAGE